These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 3322462)

  • 1. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.
    Bult H; Fret HR; Van den Bossche RM; Herman AG
    Br J Pharmacol; 1988 Dec; 95(4):1308-14. PubMed ID: 3064856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
    Gryglewski RJ; Moncada S; Palmer RM
    Br J Pharmacol; 1986 Apr; 87(4):685-94. PubMed ID: 3085757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets.
    Alheid U; Frölich JC; Förstermann U
    Thromb Res; 1987 Sep; 47(5):561-71. PubMed ID: 3499684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries.
    Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC
    Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells.
    Richards JM; Gibson IF; Martin W
    Br J Pharmacol; 1991 Jan; 102(1):203-9. PubMed ID: 1646057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin.
    Macdonald PS; Read MA; Dusting GJ
    Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells.
    White DG; Martin W
    Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled.
    de Nucci G; Gryglewski RJ; Warner TD; Vane JR
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2334-8. PubMed ID: 2832851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of production of endothelium-derived relaxing factor by cultured porcine cerebral microvessel endothelial cells.
    Kishimoto T; Oguri T; Matsumura K; Kawamoto K; Tada M
    Hum Cell; 1995 Mar; 8(1):19-24. PubMed ID: 7669748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells.
    Lückhoff A; Pohl U; Mülsch A; Busse R
    Br J Pharmacol; 1988 Sep; 95(1):189-96. PubMed ID: 3064851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E1 at clinically relevant concentrations inhibits aggregation of platelets under synergic interaction with endothelial cells.
    Koga T; Az-ma T; Yuge O
    Acta Anaesthesiol Scand; 2002 Sep; 46(8):987-93. PubMed ID: 12190800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF.
    Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J
    Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
    Hyslop S; de Nucci G
    Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets.
    Ohno M; Kishimoto T; Tada M
    Cell Biol Toxicol; 1995 Dec; 11(6):303-11. PubMed ID: 8788207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SKF 525A on the release of nitric oxide and prostacyclin from endothelial cells.
    Rees DD; Palmer RM; Moncada S
    Eur J Pharmacol; 1988 May; 150(1-2):149-54. PubMed ID: 3136027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP.
    Alheid U; Reichwehr I; Förstermann U
    Eur J Pharmacol; 1989 May; 164(1):103-10. PubMed ID: 2546782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture.
    Doni MG; Whittle BJ; Palmer RM; Moncada S
    Eur J Pharmacol; 1988 Jun; 151(1):19-25. PubMed ID: 3046956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.